Related Experiment Video
Updated: Jun 8, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Obstructive sleep disorders in Prader-Willi syndrome: The role of surgery and growth hormone
Michael A DeMarcantonio1, David H Darrow, Eric Gyuricsko
1Eastern Virginia Medical School, Norfolk, VA, USA.
Insights
Upper airway surgery alone is often insufficient for resolving obstructive sleep apnea (OSA) in Prader-Willi syndrome (PWS) patients. Pre-treatment polysomnography and combined therapies like tonsillectomy and CPAP are recommended for PWS with OSA.
Area of Science:
- Pediatric Surgery
- Sleep Medicine
- Genetics
Background:
- Prader-Willi syndrome (PWS) is associated with muscle hypotonia and obesity, leading to a high incidence of obstructive sleep apnea (OSA).
- Growth hormone therapy in PWS patients has raised concerns regarding potential exacerbation of OSA and sudden death.
- Pre-treatment evaluation for OSA and consideration of adenotonsillectomy before growth hormone therapy are suggested for PWS patients.
Purpose of the Study:
- To evaluate the effectiveness and safety of surgical interventions for obstructive sleep apnea (OSA) in patients with Prader-Willi syndrome (PWS).
Main Methods:
- Retrospective review of PWS patients who underwent adenoidectomy or adenotonsillectomy between 2001 and 2009.
- Pre-operative and post-operative polysomnography (PSG) was performed to assess the apnea-hypopnea index (AHI) and oxygen saturation.
- Analysis of changes in BMI, AHI, and oxygen saturation levels post-surgery.
Main Results:
- Five PWS patients were identified, undergoing various upper airway surgeries.
- A decrease in median AHI from 16.4 to 4.4 was observed, but without statistical significance (p=0.274).
- Improvements in mean and nadir oxygen saturation were noted but did not reach statistical significance; no intra-operative complications occurred.
Conclusions:
- Upper airway surgery alone is often insufficient for complete resolution of OSA in PWS patients.
- Children with PWS considered for growth hormone therapy require pre-treatment OSA assessment via polysomnography.
- Management of OSA in PWS may necessitate tonsillectomy and/or CPAP, with reassessment prior to hormonal therapy.
Objective:
To review the effectiveness and safety of surgical intervention for obstructive sleep apnea in Prader-Willi syndrome.
Background:
The muscle hypotonia and obesity associated with Prader-Willi syndrome (PWS) result in a high rate of obstructive sleep apnea (OSA). The use of growth hormone therapy in these patients has been associated with sudden death, raising concerns that such treatment may exacerbate obstructive sleep apnea. As a result, it has been suggested that children with PWS be evaluated for OSA and indications for adenotonsillectomy prior to instituting growth hormone therapy. The true effectiveness of surgical intervention in these cases, however, remains in doubt.
Methods:
Retrospective review of patients with a diagnosis of PWS who underwent adenoidectomy or adenotonsillectomy from January 2001 to July 2009 at a regional, tertiary care children's hospital. Patients underwent pre-operative and post-operative polysomnography. Differences between pre-operative and post-operative body-mass index (BMI), apnea-hypopnea index (AHI), and median oxygen saturation and oxygen saturation nadir were analyzed.
Results:
Five patients were identified during the study period. Three patients underwent adenotonsillectomy, 1 patient adenoidectomy alone, and another adenotonsillectomy with uvulopalatopharyngoplasty (UPPP). While median AHI was found to have decreased from 16.4 to 4.4, no statistically significant change could be demonstrated (p=0.274). Mean O(2) and nadir O(2) saturation also improved, but without reaching statistical significance. No intra-operative complications were noted.
Conclusions:
Our series, and other small case series, have demonstrated that complete resolution of sleep apnea in PWS patients is difficult to obtain with upper airway surgery alone. It is suggested that children with PWS being considered for growth hormone therapy undergo assessment for OSA by polysomnography. Patients identified with OSA should be referred for management by tonsillectomy and/or continuous positive airway pressure (CPAP) and then reassessed for residual airway obstruction prior to instituting hormonal therapy.
More Related Videos
08:03Midface Hypoplasia and Cranial Base Morphology in Syndromic Craniosynostosis: A Comparative Analysis Study Using a Predictive Regression Model
Published on: November 4, 2025
07:43Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Cushing Syndrome II: Pathophysiology
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Cushing Syndrome I: Introduction
REM Sleep Behavior Disorder
RBD is significantly associated with...